Abstract Coronavirus disease 2019 (COVID‐19) is a respiratory disorder caused by the
highly contagious severe acute respiratory syndrome coronavirus 2. The …

In the absence of effective countermeasures, human convalescent plasma has been widely
used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel …

Background: Coronavirus disease 2019 (COVID-19) is pandemic. It is critical to identify
COVID-19 patients who are most likely to develop a severe disease. This study was …

Abstract Introduction Coronavirus disease 2019 (COVID-19), caused by infection with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread widely. The …

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the
disastrous pandemic of Coronavirus Disease-2019 (COVID-19). 1-3 Although the …

The novel SARS-CoV-2 is a recently emerging virus causing a human pandemic. A great
variety of symptoms associated with COVID-19 disease, ranging from mild to severe …

BACKGROUND Elevated levels of inflammatory cytokines have been associated with poor
outcomes among COVID-19 patients. It is unknown, however, how these levels compare …

Currently severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission has
been on the rise worldwide. Predicting outcome in COVID‐19 remains challenging, and the …

Summary The World Health Organization has declared SARS-CoV-2 virus outbreak a
worldwide pandemic. However, there is very limited understanding on the immune …

Abstract The coronavirus disease-2019 (COVID-19) which caused by severe acute
respiratory syndrome-related coronavirus (SARS-CoV-2), is a pandemic threat to global …